InvestorsHub Logo
Followers 30
Posts 5248
Boards Moderated 0
Alias Born 10/16/2012

Re: Inoviorulez post# 2242

Thursday, 06/25/2015 12:35:49 PM

Thursday, June 25, 2015 12:35:49 PM

Post# of 5007

Scarring anywhere from $2 billion to $5 billion

macular degeneration $3 billion to $4 billion

CNS disorders depends:

If Rxi goes for SMA -- Spinal muscular Atrophy -- $5 billion

if Rxi branches out dermatology to Chronic Wounds $15 billion - $18 billion

It just depends what they choose for the Tyrosinase and collagenese compounds. -- chronic wounds falls under collagenese target if they choose it



Even just winning a fraction of one of the above markets will prove well for RXII. Consider the company is at about $37M market cap right now. How many multi-baggers can this one be?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News